Deadline Approaching for Shareholders in uniQure Lawsuit Filed by Gross Law Firm
On February 19, 2026, the Gross Law Firm issued an important reminder to shareholders of uniQure N.V. (NASDAQ: QURE) concerning a lead plaintiff deadline in an ongoing class action lawsuit. This notification comes as the firm encourages affected shareholders who purchased shares during the class period spanning from September 24, 2025, to October 31, 2025, to contact them for potential lead plaintiff appointments.
The lawsuit alleges significant discrepancies and misleading statements from uniQure regarding their pivotal study, which could have serious implications for their operations and stock performance. Specifically, shareholders are advised to register for this class action to ensure their involvement in any recovery that might be pursued, as appointment as a lead plaintiff is not a prerequisite for participating in the case.
The Gross Law Firm, noted for its commitment to investor rights, provides a straightforward avenue for shareholders to submit their information. By registering, shareholders will gain access to portfolio monitoring services that will keep them informed about the status of their claims as the legal processes unfold. This is an essential step, especially given the upcoming registration deadline of April 13, 2026.
Key allegations within the complaint highlight that 1) the design of uniQure’s pivotal study lacked proper FDA approval, 2) the defendants downplayed risks of delays in the Biologics License Application (BLA) submission timeline, and 3) public statements regarding the company’s business operations were not grounded in reality. These assertions raise serious questions about the company’s governance and the transparency of its communication strategy.
Shareholders who wish to learn more or initiate their registration can follow the links provided by the Gross Law Firm's public announcement, ensuring they do not miss out on their rights to potential recovery. Importantly, participation in this legal action incurs no costs or obligations to the shareholders.
The Gross Law Firm stands as a significant force in class action litigations, promoting accountability among corporations for misleading investors and advocating for the fair treatment of shareholders. They emphasize on restoring integrity within the financial markets by holding companies accountable for false or misleading statements that may inflate stock prices fraudulently.
In light of this ongoing lawsuit and the looming deadline, it’s imperative for uniQure shareholders to take proactive steps now. With the future of their investments potentially hanging in the balance, acting swiftly may provide an invaluable opportunity for redress and recovery of losses incurred due to misleading corporate conduct.
The lawsuit alleges significant discrepancies and misleading statements from uniQure regarding their pivotal study, which could have serious implications for their operations and stock performance. Specifically, shareholders are advised to register for this class action to ensure their involvement in any recovery that might be pursued, as appointment as a lead plaintiff is not a prerequisite for participating in the case.
The Gross Law Firm, noted for its commitment to investor rights, provides a straightforward avenue for shareholders to submit their information. By registering, shareholders will gain access to portfolio monitoring services that will keep them informed about the status of their claims as the legal processes unfold. This is an essential step, especially given the upcoming registration deadline of April 13, 2026.
Key allegations within the complaint highlight that 1) the design of uniQure’s pivotal study lacked proper FDA approval, 2) the defendants downplayed risks of delays in the Biologics License Application (BLA) submission timeline, and 3) public statements regarding the company’s business operations were not grounded in reality. These assertions raise serious questions about the company’s governance and the transparency of its communication strategy.
Shareholders who wish to learn more or initiate their registration can follow the links provided by the Gross Law Firm's public announcement, ensuring they do not miss out on their rights to potential recovery. Importantly, participation in this legal action incurs no costs or obligations to the shareholders.
The Gross Law Firm stands as a significant force in class action litigations, promoting accountability among corporations for misleading investors and advocating for the fair treatment of shareholders. They emphasize on restoring integrity within the financial markets by holding companies accountable for false or misleading statements that may inflate stock prices fraudulently.
In light of this ongoing lawsuit and the looming deadline, it’s imperative for uniQure shareholders to take proactive steps now. With the future of their investments potentially hanging in the balance, acting swiftly may provide an invaluable opportunity for redress and recovery of losses incurred due to misleading corporate conduct.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.